Amphastar Pharmaceuticals (AMPH) Price to Book (2014 - 2026)

Amphastar Pharmaceuticals has reported Price to Book for 13 years, with the latest figure at 1.12 in Q2 2026.

• On a quarterly basis, Price to Book fell 20.71% year-over-year to 1.12 in Q2 2026; TTM through Jun 2026 was 1.12, a 20.71% decrease from a year earlier, with the FY2025 full-year figure at 1.55, down 35.82% from the prior year.
• Price to Book was 1.12 for Q2 2026 at Amphastar Pharmaceuticals, down from 1.13 in the prior quarter.
• The five-year high for Price to Book was 4.76 in Q2 2023, with the low at 1.12 in Q2 2026.
• Average Price to Book over 5 years is 2.72, with a median of 2.72 recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Price to Book jumped 88.28% in 2022, then tumbled 50.71% in 2025.
• Over 5 years, Price to Book stood at 2.55 in 2022, then surged by 82.33% to 4.65 in 2023, then slumped by 48.07% to 2.41 in 2024, then sank by 35.82% to 1.55 in 2025, then declined by 27.9% to 1.12 in 2026.
• The last three Price to Book figures came in at 1.12 (Q2 2026), 1.13 (Q1 2026), and 1.55 (Q4 2025), per Business Quant data.